Addex Therapeutics Ltd Basic Earnings Loss Per Share From Discontinued Operations
Addex Therapeutics Ltd (ADXN) reported Basic Earnings Loss Per Share From Discontinued Operations of 0 CHF/shares for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations · last filed 2025-09-30
- Addex Therapeutics Ltd basic earnings loss per share from discontinued operations for the quarter ending 2025-06-30 was 0.00 CHF/shares, a 100.00% decline year-over-year.
- Addex Therapeutics Ltd basic earnings loss per share from discontinued operations for the quarter ending 2024-06-30 was 0.14 CHF/shares.
| Period end | Basic Earnings Loss Per Share From Discontinued Operations 3 month | Basic Earnings Loss Per Share From Discontinued Operations 6 month | Basic Earnings Loss Per Share From Discontinued Operations 12 month |
|---|---|---|---|
| 2025-06-30 | 0.00 CHF/shares 6-K · filed 2025-09-30 | 0.00 CHF/shares 6-K · filed 2025-09-30 | |
| 2024-12-31 | 0.12 CHF/shares 20-F · filed 2025-05-15 | ||
| 2024-06-30 | 0.14 CHF/shares 6-K · filed 2025-09-30 | 0.12 CHF/shares 6-K · filed 2025-09-30 | |
| 2023-12-31 | -0.11 CHF/shares 20-F · filed 2025-05-15 | ||
| 2022-12-31 | -0.22 CHF/shares 20-F · filed 2025-05-15 |